Neurology®
The most widely read and highly cited peer-reviewed Neurology journal
Quick Search
Advanced Search
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow CME: Take the course for this article:
 Volume 59, Number 11, December 10, 2002
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Nakao, Y.K.
Right arrow Articles by Eguchi, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nakao, Y.K.
Right arrow Articles by Eguchi, K.
Related Collections
Right arrow Autoimmune diseases
Right arrow Lambert-Eaton syndrome
Right arrow Paraneoplastic syndrome

Neurology 2002;59:1773-1775
© 2002 American Academy of Neurology
Brief Communications

Seronegative Lambert-Eaton myasthenic syndrome

Study of 110 Japanese patients Y.K. Nakao, MD, M. Motomura, MD, T. Fukudome, MD, T. Fukuda, MD, H. Shiraishi, MD, T. Yoshimura, MD, M. Tsujihata, MD and K. Eguchi, MD

From the First Department of Internal Medicine (Drs. Nakao, Motomura, Fukuda, Shiraishi, and Eguchi), Nagasaki University School of Medicine; Department of Neurology (Dr. Fukudome), Kawatana National Hospital; School of Health Sciences (Dr. Yoshimura), Nagasaki University; and Division of Neurology (Dr. Tsujihata), Nagasaki Kita Hospital, Japan.

Address correspondence and reprint requests to Dr. Katsumi Eguchi, the First Department of Internal Medicine, Nagasaki University School of Medicine, 1-7-1 Sakamoto, Nagasaki 852-8501, Japan; e-mail: eguchi{at}net.nagasaki-u.ac.jp

The authors characterized the clinical and immunologic features of 110 patients with Lambert-Eaton myasthenic syndrome (LEMS). Anti-P/Q-type voltage-gated calcium channels (VGCC) antibodies were detected in 85% of the patients (seropositive) but not in the rest (seronegative). Except for the indication that small cell lung carcinoma is less common in seronegative patients, no significant differences were found in the clinical characteristics of patients who had or did not have anti-P/Q-type VGCC antibodies. The results of passive transfer experiments suggest that seronegative LEMS is also an autoantibody-mediated disorder.




This article has been cited by other articles:


Home page
 JCOHome page
M. J. Titulaer, P. W. Wirtz, L. N.A. Willems, K. W. van Kralingen, P. A.E. S. Smitt, and J. J.G.M. Verschuuren
Screening for Small-Cell Lung Cancer: A Follow-Up Study of Patients With Lambert-Eaton Myasthenic Syndrome
J. Clin. Oncol., September 10, 2008; 26(26): 4276 - 4281.
[Abstract] [Full Text] [PDF]

Home page
 NeurologyHome page
N.M. Warren, M. Bennett, M. Lai, J. Forty, and T.J. Walls
Lambert-Eaton myasthenic syndrome associated with thymitis
Neurology, January 11, 2005; 64(1): 168 - 169.
[Full Text] [PDF]

Home page
 NeurologyHome page
P. W. Wirtz, J. G. van Dijk, P. A. van Doorn, B. G.M. van Engelen, A. J. van der Kooi, J. B. Kuks, A. Twijnstra, M. de Visser, L. H. Visser, J. H. Wokke, et al.
The epidemiology of the Lambert-Eaton myasthenic syndrome in the Netherlands
Neurology, July 27, 2004; 63(2): 397 - 398.
[Full Text] [PDF]

Home page
 NeurologyHome page
M. Takamori, A. Abicht, H. Lochmuller, M. Motomura, Y. K. Nakao, T. Fukudome, T. Fukuda, H. Shiraishi, T. Yoshimura, M. Tsujihata, et al.
What's in the serum of seronegative MG and LEMS?
Neurology, July 22, 2003; 61(2): 277 - 278.
[Full Text] [PDF]

Home page
 NeurologyHome page
A. Abicht and H. Lochmuller
What's in the serum of seronegative MG and LEMS?: MuSK et al.
Neurology, December 10, 2002; 59(11): 1672 - 1673.
[Full Text] [PDF]